JWCAR239

· Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JWCAR239, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma [Phase 1]